Ibogaine Research Database

692 research records indexed from PubMed. Plain-language summaries where available.

Of these, 52 are human clinical studies (trials, observational studies, or case reports), 398 are preclinical (animal or lab) studies, and 112 are reviews or meta-analyses summarizing other researchers’ data. A record appearing here does not by itself mean ibogaine is proven effective for a given condition — see each condition page’s evidence breakdown for what’s actually established.

Compare evidence by condition →

All Studies (692)Depression (56)PTSD (24)Alcohol Addiction (20)Heroin Addiction (16)Opioid Addiction (15)Cocaine Addiction (15)Anxiety (13)Methamphetamine Addiction (12)Traumatic Brain Injury (2)

All Studies(692 of 692)

Neuropharmacology

Arias, Tae, Micheli et al.· Neuropharmacology· 2020· PMID: 32540451
Preclinical (Animal)

The primary aim of this study was to determine the anti-neuropathic activity of (±)-18-methoxycoronaridine [(±)-18-MC] and (+)-catharanthine in mice by using the oxaliplatin-induced neuropathic pain paradigm and cold plate test. The results showed that both coronaridine congeners...

Progress in neuro-psychopharmacology & biological psychiatry

Arias, Do Rego, Do Rego et al.· Prog Neuropsychopharmacol Biol Psychiatry· 2020· PMID: 32194202
Preclinical (Animal)

To determine whether (+)-catharanthine induces sedative- or anxiolytic/anxiogenic-like activity in male mice, proper animal paradigms were used. The results showed that (+)-catharanthine induces sedative-like activity in the 63-72 mg/Kg dose range in a flumazenil-insensitive mann...

A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats.

Rodrı Guez, Urbanavicius, Prieto et al.· ACS Chem Neurosci· 2020· PMID: 32330007
Preclinical (Animal)

Anecdotal reports and open-label case studies in humans indicated that the psychedelic alkaloid ibogaine exerts profound antiaddictive effects. Ample preclinical evidence demonstrated the efficacy of ibogaine, and its main metabolite, noribogaine, in substance-use-disorder rodent...

Ibogaine therapy for addiction: Consumer views from online fora.

Barber, Gardner, Savic et al.· Int J Drug Policy· 2020· PMID: 32693321
Survey / Qualitative

Background Ibogaine is a psychedelic drug used by for-profit clinics and lay-people to treat addiction, despite some reported fatalities and a lack of rigorous clinical research. Little is known about ibogaine therapy from a consumer perspective. Online discussions generate and d...

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans.

Davis, Averill, Sepeda· Chronic stress (Thousand Oaks, Calif.)· 2020· PMID: 32704581
Preclinical (Lab)

U.S. Special Operations Forces Veterans are at increased risk for a variety of mental health problems and cognitive impairment associated with military service. Current treatments are lacking in effectiveness and adherence. Therefore, this study examined psychedelic treatment wit...

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.

Breeksema, Niemeijer, Krediet· CNS drugs· 2020· PMID: 32803732
Systematic Review

Interest in the use of psychedelic substances for the treatment of mental disorders is increasing. Processes that may affect therapeutic change are not yet fully understood. Qualitative research methods are increasingly used to examine patient accounts; however, currently, no sys...

Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies.

Zeppelin, Ladefoged, Sinning et al.· Neuropharmacology· 2019· PMID: 30807752
Review

The serotonin transporter (SERT) belongs to the monoamine transporter family, which also includes the dopamine and norepinephrine transporters. SERT is essential for regulating serotonergic signaling by the reuptake of serotonin from the synaptic cleft back into the presynaptic n...

On Addiction, Complexity, and Freedom: Toward a Liberation-Focused Addiction Treatment.

Kellogg· J Psychoactive Drugs· 2019· PMID: 30653394
Unclassified

This article outlines a liberation-focused model of addiction treatment. Drawing on the Latin root word "addictus", addiction is seen as slavery and freedom, rather than the cessation of drug and alcohol use, is proposed as a viable, alternative treatment goal. Freedom is defined...

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits.

Marton, González, Rodríguez-Bottero et al.· Front Pharmacol· 2019· PMID: 30890941
Preclinical (Lab)

Ibogaine is an atypical psychedelic alkaloid, which has been subject of research due to its reported ability to attenuate drug-seeking behavior. Recent work has suggested that ibogaine effects on alcohol self-administration in rats are related to the release of Glial cell Derived...

Natural product research

Wang, Li, Liu et al.· Nat Prod Res· 2019· PMID: 29852800
Unclassified

One known bis-indole alkaloid-voacamine was isolated from Voacanga africana Stapf and Surface Plasmon Resonance imaging (SPRi) exprement showed that this alkaloid could be combine with Protein Tyrosine Phosphatase1B (PTP1B). Then the PTP1B activity inhibition experiment display t...

Impact of sex-specific differences in calculating the pretest probability of obstructive coronary artery disease in symptomatic patients: a coronary computed tomographic angiography study.

Zhang, Liu, Zhang et al.· Coron Artery Dis· 2019· PMID: 30629000
Unclassified

Little is known about the impact of sex-specific differences in calculating the pretest probability (PTP) of obstructive coronary artery disease. We sought to determine whether the calculation of PTP differ by sex in symptomatic patients referred to coronary computed tomographic ...

Influence of lipid composition on the ability of liposome loaded voacamine to improve the reversion of doxorubicin resistant osteosarcoma cells.

Giansanti, Condello, Altieri et al.· Chem Phys Lipids· 2019· PMID: 31229409
Unclassified

The plant alkaloid voacamine (VOA) displays many interesting pharmacological activities thus, considering its scarce solubility in water, its encapsulation into liposome formulations for its delivery is an important goal. Different cationic liposome formulations containing a phos...

Metabolite Profiling of Anti-Addictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae).

Krengel, Chevalier, Dickinson et al.· Chem Biodivers· 2019· PMID: 30618175
Preclinical (Lab)

Ibogaine and other ibogan type alkaloids present anti-addictive effects against several drugs of abuse and occur in different species of the Apocynaceae family. In this work, we used gas chromatography-mass spectrometry (GC/MS) and principal component analysis (PCA) in order to c...

The α3β4 nicotinic acetylcholine receptor antagonist 18-Methoxycoronaridine decreases binge-like ethanol consumption in adult C57BL/6J mice.

Miller, Ruggery, Kamens· Alcohol· 2019· PMID: 30496781
Preclinical (Animal)

Binge alcohol drinking is a health burden in the United States, which has an alarming economic impact. Unfortunately, medications available for alcohol abuse have low efficacy or adverse side effects, creating a need to evaluate novel therapies. Growing research suggests that 18-...

Conformational dynamics of the human serotonin transporter during substrate and drug binding.

Möller, Slivacka, Nielsen· Nature communications· 2019· PMID: 30976000
Preclinical (Lab)

The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e...

The paradox of iboga: intoxication by a natural detoxification remedy.

Matamoros-Castillo, Jávega-Manjón, Sierra-San Miguel et al.· Actas Esp Psiquiatr· 2019· PMID: 31017277
Case Report

Biosynthesis of an Anti-Addiction Agent from the Iboga Plant.

Farrow, Kamileen, Caputi et al.· J Am Chem Soc· 2019· PMID: 31364847
Unclassified

(-)-Ibogaine and (-)-voacangine are plant derived psychoactives that show promise as treatments for opioid addiction. However, these compounds are produced by hard to source plants, making these chemicals difficult for broad-scale use. Here we report the complete biosynthesis of ...

Hallucinogens and Their Therapeutic Use: A Literature Review.

Begola, Schillerstrom· J Psychiatr Pract· 2019· PMID: 31505518
Review

The exploration of possible therapeutic benefits of hallucinogenic substances has undergone a revitalization in the past decade. This literature review investigated the published literature regarding the psychotherapeutic uses of hallucinogens in psychiatric disorders. The result...

Extraction and Conversion Studies of the Antiaddictive Alkaloids Coronaridine, Ibogamine, Voacangine, and Ibogaine from Two Mexican Tabernaemontana Species (Apocynaceae).

Krengel, Mijangos, Reyes-Lezama et al.· Chem Biodivers· 2019· PMID: 31095891
Preclinical (Lab)

Several species from the Apocynaceae family, such as Tabernanthe iboga, Voacanga africana, and many Tabernaemontana species, produce ibogan type alkaloids, some of which present antiaddictive properties. In this study, we used gas chromatography/mass spectrometry (GC/MS) to exami...

Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands.

Floresta, Dichiara, Gentile et al.· Int J Mol Sci· 2019· PMID: 30678129
Preclinical (Lab)

Ibogaine is a psychoactive indole alkaloid with high affinity for several targets including the σ₂ receptor. Indeed, extensive data support the involvement of the σ₂ receptor in neurological disorders, including Alzheimer's disease, schizophrenia, alcohol abuse and pain. Due to i...

Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.

Coleman, Yang, Zhao et al.· Nature· 2019· PMID: 31019304
Unclassified

The serotonin transporter (SERT) regulates neurotransmitter homeostasis through the sodium- and chloride-dependent recycling of serotonin into presynaptic neurons1-3. Major depression and anxiety disorders are treated using selective serotonin reuptake inhibitors-small molecules ...

[Neurotrophic mechanisms of psychedelic therapy].

Corne, Mongeau· Biologie aujourd'hui· 2019· PMID: 31829932
Review

Psychedelic drugs, often referred to as hallucinogens, are quite distinct from other classes of psychotropic drugs. Although the subjective and behavioral effects they induce are quite dramatic, they possess little addictive potential when compared to nicotine, alcohol or opiates...

Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.

Grogan, Gerona, Snow· The Journal of emergency medicine· 2019· PMID: 31630892
Case Report

Ibogaine is a psychoactive indole alkaloid that has been investigated for use as a treatment for opioid addiction. While not commercially available in the United States, it is available via Internet suppliers. Ibogaine use has been associated with significant cardiac and neurolog...

Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder.

Brown, Noller, Denenberg· Journal of psychoactive drugs· 2019· PMID: 30967101
Observational Study

This article examines the therapeutic potential of ibogaine, a powerful oneiric alkaloid derived from Tabernanthe iboga, through exploring the subjective experiences of 44 participants from two observational treatment studies for opioid use disorder. Following treatment with ibog...

Nepenthe-Like Indole Alkaloids with Antimicrobial Activity from Ervatamia chinensis.

Yu, Qin, Ding et al.· Org Lett· 2018· PMID: 29927253
Preclinical (Lab)

Two monoterpenoid indole alkaloid erchinines A (1) and B (2), possessing unique 1,4-diazepine fused with oxazolidine architecture and three hemiaminals, were isolated from Ervatamia chinensis. Their structures were elucidated on the basis of intensive spectroscopic analysis, and ...

Wastewater-based epidemiology in low Human Development Index states: bias in consumption monitoring of illicit drugs.

Devault, Maguet, Merle et al.· Environ Sci Pollut Res Int· 2018· PMID: 30109683
Review

Wastewater-based epidemiology is a promising approach worldwide, and its application is currently being developed in non-advanced economies. This technology, based on known toxicokinetic data initially used to detect illicit drugs in well-managed and maintained local sewer networ...

SLC6 Transporter Folding Diseases and Pharmacochaperoning.

Freissmuth, Stockner, Sucic· Handb Exp Pharmacol· 2018· PMID: 29086036
Review

The human genome encodes 19 genes of the solute carrier 6 (SLC6) family; non-synonymous changes in the coding sequence give rise to mutated transporters, which are misfolded and thus cause diseases in the affected individuals. Prominent examples include mutations in the transport...

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.

Schenberg· Front Pharmacol· 2018· PMID: 30026698
Preclinical (Lab)

Mental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a paradigmatic crisis. A radical...

Cardiac arrest after ibogaine intoxication.

Steinberg, Deyell· J Arrhythm· 2018· PMID: 30167018
Case Report

Ibogaine is a psychoactive herbal medication with alleged antiaddiction properties. We report a case of ibogaine intoxication mimicking Long-QT syndrome resulting in ventricular flutter and nearby cardiac arrest. A 61-year-old man experienced massive QT prolongation and ventricul...

Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile.

González, Prieto, Rodríguez et al.· Front Pharmacol· 2018· PMID: 29755349
Preclinical (Lab)

Ibogaine is a potent psychedelic alkaloid that has been the focus of intense research because of its intriguing anti-addictive properties. According to anecdotic reports, ibogaine has been originally classified as an oneirogenic psychedelic; i.e., induces a dream-like cognitive a...

Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways.

Arias, Lykhmus, Uspenska et al.· Neurochem Int· 2018· PMID: 29277577
Preclinical (Animal)

In contrast to plasma membrane-expressed nicotinic acetylcholine receptors (nAChRs), mitochondrial nAChRs function in an ion-independent manner by triggering intra-mitochondrial kinases that regulate the release of cytochrome c (Cyt c), an important step in cellular apoptosis. Th...

Journal of food bioactives : an official scientific publication of the International Society of Nutraceuticals and Functional Foods (ISNFF)

Bading-Taika, Akinyeke, Magana et al.· J Food Bioact· 2018· PMID: 30582133
Preclinical (Lab)

Preparations of the root bark of Tabernanthe iboga have long been used in Central and West African traditional medicine to combat fatigue, as a neuro-stimulant in rituals, and for treatment of diabetes. The principal alkaloid of T. iboga, ibogaine, has attracted attention in many...

The Effects of Ibogaine on Uterine Smooth Muscle Contractions: Relation to the Activity of Antioxidant Enzymes.

Oreščanin-Dušić, Tatalović, Vidonja-Uzelac et al.· Oxid Med Cell Longev· 2018· PMID: 29599898
Preclinical (Lab)

Ibogaine is an indole alkaloid originally extracted from the root bark of the African rainforest shrub Tabernanthe iboga. It has been explored as a treatment for substance abuse because it interrupts drug addiction and relieves withdrawal symptoms. However, it has been shown that...

The Journal of biological chemistry

Farrow, Kamileen, Meades et al.· J Biol Chem· 2018· PMID: 30030374
Preclinical (Lab)

Monoterpenoid indole alkaloids are a large (∼3000 members) and structurally diverse class of metabolites restricted to a limited number of plant families in the order Gentianales. Tabernanthe iboga or iboga (Apocynaceae) is native to western equatorial Africa and has been used in...

Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.

Malcolm, Polanco, Barsuglia· J Psychoactive Drugs· 2018· PMID: 29608409
Unclassified

Opioid use disorder (OUD) is currently an epidemic in the United States (US) and ibogaine is reported to have the ability to interrupt opioid addiction by simultaneously mitigating withdrawal and craving symptoms. This study examined opioid withdrawal and drug craving scores in 5...

Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.

Knuijver, Belgers, Markus et al.· J Clin Psychopharmacol· 2018· PMID: 30300292
Case Report

A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.

Davis, Renn, Windham-Herman et al.· J Psychoactive Drugs· 2018· PMID: 30020025
Unclassified

We examined persisting effects, self-perceived challenges, and potential benefits associated with positive outcomes following ibogaine detoxification using data collected as part of a larger online retrospective study of 73 patients who received treatment for chronic opioid use i...

On the relationship between ibogaine and noribogaine.

Yip, Deng· Clin Toxicol (Phila)· 2018· PMID: 28681614
Unclassified

Breaking the cycle of opioid use disorder with Ibogaine.

C Mash· The American journal of drug and alcohol abuse· 2018· PMID: 29215917
Unclassified

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.

Barsuglia, Polanco, Palmer· Progress in brain research· 2018· PMID: 30471678
Unclassified

Ibogaine is a plant-derived alkaloid and dissociative psychedelic that demonstrates anti-addictive properties with several substances of abuse, including alcohol. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic known to occasion potent mystical-t...

DARK Classics in Chemical Neuroscience: Ibogaine.

Wasko, Witt-Enderby, Surratt· ACS chemical neuroscience· 2018· PMID: 30216039
Review

The West African iboga plant has been used for centuries by the Bwiti and Mbiri tribes to induce hallucinations during religious ceremonies. Ibogaine, the principal alkaloid responsible for iboga's psychedelic properties, was isolated and sold as an antidepressant in France for d...

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Corkery· Progress in brain research· 2018· PMID: 30471681
Review

Ibogaine is an indole alkaloid found in the root bark of the Iboga shrub native to west Africa possessing hallucinogenic properties. For centuries it has been used in religious ceremonies and to gain spiritual enlightenment. However, since the early 1960s, its apparent ability to...

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.

Mash, Duque, Page· Frontiers in pharmacology· 2018· PMID: 29922156
Preclinical (Lab)

Ibogaine may be effective for transitioning opioid and cocaine dependent individuals to sobriety. American and European self-help groups provided public testimonials that ibogaine alleviated drug craving and opioid withdrawal symptoms after only a single dose administration. Prec...

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.

Brown, Alper· The American journal of drug and alcohol abuse· 2018· PMID: 28541119
Observational Study

Ibogaine is a monoterpene indole alkaloid used in medical and nonmedical settings for the treatment of opioid use disorder. Its mechanism of action is apparently novel. There are no published prospective studies of drug use outcomes with ibogaine. To study outcomes following opio...

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.

Noller, Frampton, Yazar-Klosinski· The American journal of drug and alcohol abuse· 2018· PMID: 28402682
Observational Study

The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. To examine longitudinal treatment effec...

The Iboga Alkaloids.

Lavaud, Massiot· Prog Chem Org Nat Prod· 2017· PMID: 28194562
Review

Iboga alkaloids are a particular class of indolomonoterpenes most often characterized by an isoquinuclidine nucleus. Their first occurrence was detected in the roots of Tabernanthe iboga, a sacred plant to the people of Gabon, which made it cult object. Ibogaine is the main repre...

The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.

de Moura, McMahon· Psychopharmacology (Berl)· 2017· PMID: 28028600
Preclinical (Animal)

The extent to which non-α4β2 versus α4β2* nAChRs contribute to the behavioral effects of varenicline and other nAChR agonists is unclear. The purpose of this study was to characterize the discriminative stimulus effects of varenicline and nicotine using various nAChR agonists and...

The Journal of biological chemistry

Asjad, Kasture, El-Kasaby et al.· J Biol Chem· 2017· PMID: 28972153
Preclinical (Animal)

Point mutations in the gene encoding the human dopamine transporter (hDAT, SLC6A3) cause a syndrome of infantile/juvenile dystonia and parkinsonism. To unravel the molecular mechanism underlying these disorders and investigate possible pharmacological therapies, here we examined ...

Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.

Arias, Jin, Feuerbach et al.· Int J Biochem Cell Biol· 2017· PMID: 29042244
Preclinical (Animal)

The inhibitory activity of coronaridine congeners on human (h) α4β2 and α7 nicotinic acetylcholine receptors (AChRs) is determined by Ca2+ influx assays, whereas their effects on neurons in the ventral inferior (VI) aspect of the mouse medial habenula (MHb) are determined by patc...

Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.

Chowdhury, Kumar, Godinho et al.· Biochem Pharmacol· 2017· PMID: 28483460
Preclinical (Animal)

Indole alkaloids possess a large spectrum of biological activities including anti-protozoal action. Here we report for the first time that voacamine, isolated from the plant Tabernaemontana coronaria, is an antiprotozoal agent effective against a large array of trypanosomatid par...

← PrevPage 5 / 14Next →